MedPath

University of Iowa

University of Iowa logo
🇺🇸United States
Ownership
Private
Established
1847-02-25
Employees
251
Market Cap
-
Website
http://www.uiowa.edu

Clinical Trials

271

Active:12
Completed:167

Trial Phases

6 Phases

Early Phase 1:7
Phase 1:18
Phase 2:30
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (220 trials with phase data)• Click on a phase to view related trials

Not Applicable
137 (62.3%)
Phase 2
30 (13.6%)
Phase 4
24 (10.9%)
Phase 1
18 (8.2%)
Early Phase 1
7 (3.2%)
Phase 3
4 (1.8%)

Effect of Terazosin on ATP Levels in People With Amyotrophic Lateral Sclerosis

Not Applicable
Not yet recruiting
Conditions
Amyotrophic Lateral Sclerosis
Adenosine Triphosphate Activities
Interventions
First Posted Date
2025-11-04
Last Posted Date
2025-11-05
Lead Sponsor
University of Iowa
Target Recruit Count
15
Registration Number
NCT07224269
Locations
🇺🇸

University of Iowa Health Care, Iowa City, Iowa, United States

Comparing Relative Strengths of Statistical Associations Between Psychological Traits and Vaccination-Related Outcomes I

Not Applicable
Completed
Conditions
Vaccination
Vaccination Hesitancy
Vaccination Promotion
Psychological Aspects
First Posted Date
2025-09-15
Last Posted Date
2025-09-16
Lead Sponsor
University of Iowa
Target Recruit Count
1786
Registration Number
NCT07172074
Locations
🇺🇸

University of Iowa, Iowa City, Iowa, United States

Paediatric Post-TB Pulmonary Rehab Study

Not Applicable
Recruiting
Conditions
Tuberculosis in Children
Chronic Lung Disease
Post Tuberculosis
First Posted Date
2025-08-01
Last Posted Date
2025-08-11
Lead Sponsor
University of Iowa
Target Recruit Count
40
Registration Number
NCT07097961
Locations
🇺🇬

MU-JHU Care Ltd/MU-JHU Research Collaboration, Kampala, Uganda

PERceptions of Diltiazem Versus ADEnosine for Treatment of Supraventricular Tachycardia in the Emergency Department

Recruiting
Conditions
Supraventricular Tachycardia (SVT)
Interventions
Drug: IV adenosine
Drug: IV diltiazem
First Posted Date
2025-07-25
Last Posted Date
2025-08-03
Lead Sponsor
University of Iowa
Target Recruit Count
20
Registration Number
NCT07086560
Locations
🇺🇸

University of Iowa Health Care, Iowa City, Iowa, United States

E-Tailored Pain Management Support for Dementia Family Caregivers: Feasibility of the PACE-app

Not Applicable
Recruiting
Conditions
Chronic Pain
Care Giving Burden
Dementia
Pain Management
Palliative Care
First Posted Date
2025-06-24
Last Posted Date
2025-06-29
Lead Sponsor
University of Iowa
Target Recruit Count
60
Registration Number
NCT07032350
Locations
🇺🇸

College of Nursing, Iowa City, Iowa, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 55
  • Next

News

Uric Acid Shows Promise as Novel Add-On Therapy for Ischemic Stroke in NIH-Funded Study

NIH-funded preclinical research demonstrates that uric acid treatment significantly improved sensorimotor function and survival rates in rodents 30 days after ischemic stroke.

Beta-Blockers Linked to Delayed Onset and Slower Progression of Huntington's Disease

A study using the Enroll-HD database found that beta-blocker use is associated with delayed motor diagnosis in premanifest Huntington's disease (HD).

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.